↓ Skip to main content

Natalizumab in the treatment of multiple sclerosis

Overview of attention for article published in Therapeutics and Clinical Risk Management, July 2009
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (78th percentile)
  • High Attention Score compared to outputs of the same age and source (89th percentile)

Mentioned by

patent
5 patents

Readers on

mendeley
19 Mendeley